Found: 18
Select item for more details and to access through your institution.
Independent strong association of HLA-A* 02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement.
- Published in:
- Scientific Reports, 2014, p. 1, doi. 10.1038/srep04862
- By:
- Publication type:
- Article
Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
- Published in:
- Journal of Human Genetics, 2013, v. 58, n. 6, p. 317, doi. 10.1038/jhg.2013.37
- By:
- Publication type:
- Article
Impact of the haplotype CYP3A4*16B harboring the Thr185Ser substitution on paclitaxel metabolism in Japanese patients with cancer<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 2, p. 179, doi. 10.1016/j.clpt.2006.04.012
- By:
- Publication type:
- Article
UGT1A1 Haplotypes Associated with Reduced Glucuronidation and Increased Serum Bilirubin in Irinotecan-administered Japanese Patients with Cancer<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2004, v. 75, n. 6, p. 501, doi. 10.1016/j.clpt.2004.01.010
- By:
- Publication type:
- Article
Genetic variations and haplotype structures of the DPYD gene encoding dihydropyrimidine dehydrogenase in Japanese and their ethnic differences.
- Published in:
- Journal of Human Genetics, 2007, v. 52, n. 10, p. 804, doi. 10.1007/s10038-007-0186-6
- By:
- Publication type:
- Article
Genetic polymorphisms of FCGR2A encoding Fcγ receptor IIa in a Japanese population and functional analysis of the L273P variant.
- Published in:
- Immunogenetics, 2012, v. 64, n. 12, p. 869, doi. 10.1007/s00251-012-0646-9
- By:
- Publication type:
- Article
Effect of food on the bioavailability of cyclandelate from commercial capsules.
- Published in:
- Clinical Pharmacology & Therapeutics, 1991, v. 49, n. 6, p. 641, doi. 10.1038/clpt.1991.81
- By:
- Publication type:
- Article
Haplotype structures ofEPHX1and their effects on the metabolism of carbamazepine-10,11-epoxide in Japanese epileptic patients.
- Published in:
- European Journal of Clinical Pharmacology, 2005, v. 61, n. 1, p. 25, doi. 10.1007/s00228-004-0878-1
- By:
- Publication type:
- Article
Cytosolic and microsomal activation of doxifluridine and tegafur to produce 5-fluorouracil in human liver.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Application of a Combination of a Knowledge-Based Algorithm and 2-Stage Screening to Hypothesis-Free Genomic Data on Irinotecan-Treated Patients for Identification of a Candidate Single Nucleotide Polymorphism Related to an Adverse Effect.
- Published in:
- PLoS ONE, 2014, v. 9, n. 8, p. 1, doi. 10.1371/journal.pone.0105160
- By:
- Publication type:
- Article
Absence of ethnic differences in the pharmacokinetics of moxifloxacin, simvastatin, and meloxicam among three East Asian populations and Caucasians.
- Published in:
- British Journal of Clinical Pharmacology, 2016, v. 81, n. 6, p. 1078, doi. 10.1111/bcp.12884
- By:
- Publication type:
- Article
Association of carboxylesterase 1A genotypes with irinotecan pharmacokinetics in Japanese cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 70, n. 2, p. 222, doi. 10.1111/j.1365-2125.2010.03695.x
- By:
- Publication type:
- Article
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphisms.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Population Pharmacokinetics of Gemcitabine and Its Metabolite in Japanese Cancer Patients.
- Published in:
- Clinical Pharmacokinetics, 2010, v. 49, n. 8, p. 549, doi. 10.2165/11532970-000000000-00000
- By:
- Publication type:
- Article
Additive effects of drug transporter genetic polymorphisms on irinotecan pharmacokinetics/pharmacodynamics in Japanese cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 1, p. 95, doi. 10.1007/s00280-009-1138-y
- By:
- Publication type:
- Article
Impact of CYP3A4 haplotypes on irinotecan pharmacokinetics in Japanese cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 62, n. 3, p. 529, doi. 10.1007/s00280-007-0634-1
- By:
- Publication type:
- Article
HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients.
- Published in:
- Epilepsia (Series 4), 2010, v. 51, n. 12, p. 2461, doi. 10.1111/j.1528-1167.2010.02766.x
- By:
- Publication type:
- Article
HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions.
- Published in:
- Epilepsia (Series 4), 2010, v. 51, n. 2, p. 297, doi. 10.1111/j.1528-1167.2009.02269.x
- By:
- Publication type:
- Article